Paper19191908
Role of high-affinity HLA-DP specific CLIP-derived peptides in beryllium binding to the HLA-DPGlu69 berylliosis-associated molecules and presentation to beryllium-sensitized T cells.
Amicosante M and 3 others. Immunology, 2009. Cited by 10 papers, by iCite.
Cite this record
ConductScience Library. Role of high-affinity HLA-DP specific CLIP-derived peptides in beryllium binding to the HLA-DPGlu69 berylliosis-associated molecules and presentation to beryllium-sensitized T cells. Papers, record 19191908. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/19191908
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Role of high-affinity HLA-DP specific CLIP-derived peptides in beryllium binding to the HLA-DPGlu69 berylliosis-associated molecules and presentation to beryllium-sensitized T cells.
- PubMed
- Publication types
- Journal Article, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, Non-P.H.S.
- PubMed
Topics13
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Antigens, Differentiation, B-Lymphocyte | Major topic |
| Berylliosis | Major topic |
| Beryllium | Major topic |
| HLA-DP Antigens | Major topic |
| Histocompatibility Antigens Class II | Major topic |
| T-Lymphocytes | Major topic |
| Adult | |
| Female | |
| Humans | |
| Interferon-gamma | |
| Lymphocyte Activation | |
| Male | |
| Middle Aged |
Source PubMed
References30
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 11897645 | Human leukocyte antigen Class II amino acid epitopes: susceptibility and progression markers for beryllium hypersensitivity. | Am J Respir Crit Care Med | 2002 | https://conductscience.org/library/papers/11897645 | PubMed |
| 2 | 12438445 | Target organ localization of memory CD4(+) T cells in patients with chronic beryllium disease. | J Clin Invest | 2002 | https://conductscience.org/library/papers/12438445 | PubMed |
| 3 | 11207315 | HLA-DP allele-specific T cell responses to beryllium account for DP-associated susceptibility to chronic beryllium disease. | J Immunol | 2001 | https://conductscience.org/library/papers/11207315 | PubMed |
| 4 | 15273960 | The association between HLA-DPB1Glu69 and chronic beryllium disease and beryllium sensitization. | Am J Ind Med | 2004 | https://conductscience.org/library/papers/15273960 | PubMed |
| 5 | 12471126 | HLA-DP4, the most frequent HLA II molecule, defines a new supertype of peptide-binding specificity. | J Immunol | 2002 | https://conductscience.org/library/papers/12471126 | PubMed |
| 6 | 12697658 | Functional analysis of HLA-DP polymorphism: a crucial role for DPbeta residues 9, 11, 35, 55, 56, 69 and 84-87 in T cell allorecognition and peptide binding. | Int Immunol | 2003 | https://conductscience.org/library/papers/12697658 | PubMed |
| 7 | 11551429 | Beryllium sensitivity is linked to HLA-DP genotype. | Toxicology | 2001 | https://conductscience.org/library/papers/11551429 | PubMed |
| 8 | 14617029 | Detailed analysis of the effects of Glu/Lys beta69 human leukocyte antigen-DP polymorphism on peptide-binding specificity. | Tissue Antigens | 2003 | https://conductscience.org/library/papers/14617029 | PubMed |
| 9 | 14662898 | Influence of MHC class II in susceptibility to beryllium sensitization and chronic beryllium disease. | J Immunol | 2003 | https://conductscience.org/library/papers/14662898 | PubMed |
| 10 | 12615898 | Components of the ligand for a Ni++ reactive human T cell clone. | J Exp Med | 2003 | https://conductscience.org/library/papers/12615898 | PubMed |
| 11 | 16272364 | Beryllium presentation to CD4+ T cells is dependent on a single amino acid residue of the MHC class II beta-chain. | J Immunol | 2005 | https://conductscience.org/library/papers/16272364 | PubMed |
| 12 | 16315779 | Role of the berylliosis-associated HLA-DPGlu69 supratypic variant in determining the response to beryllium in a blood T-cells beryllium-stimulated proliferation test. | Sarcoidosis Vasc Diffuse Lung Dis | 2005 | https://conductscience.org/library/papers/16315779 | PubMed |
| 13 | 16372883 | Peptide-based immunotherapy: a novel strategy for allergic disease. | Expert Rev Vaccines | 2005 | https://conductscience.org/library/papers/16372883 | PubMed |
| 14 | 8105536 | HLA-DPB1 glutamate 69: a genetic marker of beryllium disease. | Science | 1993 | https://conductscience.org/library/papers/8105536 | PubMed |
| 15 | 16697706 | T cell recognition in chronic beryllium disease. | Clin Immunol | 2006 | https://conductscience.org/library/papers/16697706 | PubMed |
| 16 | 11716174 | Major histocompatibility locus genetic markers of beryllium sensitization and disease. | Eur Respir J | 2001 | https://conductscience.org/library/papers/11716174 | PubMed |
| 17 | 10415070 | Differential susceptibilities to chronic beryllium disease contributed by different Glu69 HLA-DPB1 and -DPA1 alleles. | J Immunol | 1999 | https://conductscience.org/library/papers/10415070 | PubMed |
| 18 | 15778396 | Activation pathways implicate anti-HLA-DP and anti-LFA-1 antibodies as lead candidates for intervention in chronic berylliosis. | J Immunol | 2005 | https://conductscience.org/library/papers/15778396 | PubMed |
| 19 | 15565337 | Characterization of natural peptide ligands from HLA-DP2: new insights into HLA-DP peptide-binding motifs. | Immunogenetics | 2005 | https://conductscience.org/library/papers/15565337 | PubMed |
| 20 | 16109363 | Glatiramer acetate in multiple sclerosis: update on potential mechanisms of action. | Lancet Neurol | 2005 | https://conductscience.org/library/papers/16109363 | PubMed |
Cited by7
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 10 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42382774 | HLA DP/DRA molecule regulates systemic inflammation and neuroinflammation, aggravates cognitive impairment and long-term anxiety in murine model of sepsis-associated encephalopathy. | Front Immunol | 2026 | https://conductscience.org/library/papers/42382774 | PubMed |
| 33927005 | Pulmonary granulomatosis of genetic origin. | Eur Respir Rev | 2021 | https://conductscience.org/library/papers/33927005 | PubMed |
| 26685315 | Beryllium-Induced Hypersensitivity: Genetic Susceptibility and Neoantigen Generation. | J Immunol | 2016 | https://conductscience.org/library/papers/26685315 | PubMed |
| 22862845 | Peptide binding to HLA-DP proteins at pH 5.0 and pH 7.0: a quantitative molecular docking study. | BMC Struct Biol | 2012 | https://conductscience.org/library/papers/22862845 | PubMed |
| 21752305 | Peptide binding prediction for the human class II MHC allele HLA-DP2: a molecular docking approach. | BMC Struct Biol | 2011 | https://conductscience.org/library/papers/21752305 | PubMed |
| 20981472 | Chronic beryllium disease: an updated model interaction between innate and acquired immunity. | Biometals | 2011 | https://conductscience.org/library/papers/20981472 | PubMed |
| 20356827 | Crystal structure of HLA-DP2 and implications for chronic beryllium disease. | Proc Natl Acad Sci U S A | 2010 | https://conductscience.org/library/papers/20356827 | PubMed |
Genes3
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| CLIP1 | 6249 | PubTator's text mining | https://conductscience.org/library/genes/6249 | NCBI Gene |
| HLA-DPB1 | 3115 | PubTator's text mining | https://conductscience.org/library/genes/3115 | NCBI Gene |
| IFNG | 3458 | PubTator's text mining | https://conductscience.org/library/genes/3458 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/19191908
GET https://conductscience.org/api/papers/v1/19191908/references?page=2